Ceftolozane/Tazobactam for Treating Children With Exacerbations of Cystic Fibrosis Due to Pseudomonas aeruginosa: A Review of Available Data

Ceftolozane-tazobactam is a novel fifth-generation cephalosporin/β-lactamase inhibitor combination recently approved for treatment of both complicated intra-abdominal and urinary tract infections in adults. Considering its potent bactericidal activity against Pseudomonas aeruginosa, it might represe...

Descripción completa

Detalles Bibliográficos
Autores principales: Garazzino, Silvia, Altieri, Elena, Silvestro, Erika, Pruccoli, Giulia, Scolfaro, Carlo, Bignamini, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214539/
https://www.ncbi.nlm.nih.gov/pubmed/32432060
http://dx.doi.org/10.3389/fped.2020.00173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214539/
https://www.ncbi.nlm.nih.gov/pubmed/32432060
http://dx.doi.org/10.3389/fped.2020.00173

Ejemplares similares